Q BioMed Inc QBIO
$0.00
Last Updated: Mar 30, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Q BioMed Inc. Stock Analysis QBIO
United States Health Care Nano Cap Q BioMed, Inc. operates as a biomedical acceleration and development company. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2014-11-17. The firm is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The Company’s pipeline products include Strontium89, QBM-001, UTTROSIDE-B, and MAN 01. Strontium89 treats pain from bone metastases caused by multiple primary tumors. Strontium Chloride Sr-89 Injection, USP is indicated for the relief of bone pain in patients with painful skeletal metastases. QBM-001 is designed to alleviate the condition and allow toddlers to actively develop language and speech and avoid life-long speech and intellectual disabilities caused from being non-verbal. UTTROSIDE-B is a potential chemotherapeutic for liver cancer. MAN-01 is for the treatment of primary open-angle glaucoma, wherein it is developing a small molecule in the form of an easy to administer eye drop to reduce intra-ocular eye pressure (IOP), a key risk factor in the progression of glaucoma.
Q BioMed Inc (QBIO) Chart
Financial Metrics & Statements of Q BioMed Inc (QBIO)
FAQ's for Q BioMed Inc (QBIO)
- As of August 2026, Q BioMed Inc QBIO is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Q BioMed Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Q BioMed Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Q BioMed Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Q BioMed Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Q BioMed Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Q BioMed Inc (QBIO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
